Abstract

Objective To explore the role and possible underlying mechanism of miR-486 in ovarian cancer (OC) cells. Methods The expression of miR-486 and CADM1 was detected by qRT-PCR in OC tissues and adjacent nontumor tissues and OC cell lines. The dual-luciferase reporter gene system was used to determine the targeting relationship between miR-486 and CADM1. CCK-8, colony formation assay, Transwell, and flow cytometry were performed to detect cell proliferation, cell invasion, cell cycle progression, and the apoptotic cell death, respectively. Western blot was carried out to detect the expression of CADM1 protein and the proteins associated with cell cycle progression. Results miR-486 was significantly upregulated in OC tissues and cells, while CADM1 expression was significantly downregulated. Dual-luciferase reporter assays further confirmed that CADM1 was a target gene of miR-486. Interference with miR-486 could inhibit the proliferation and invasion and promoted the apoptosis of SKOV3 cells. Knocking down both miR-486 and CADM1 significantly increased the SKOV3 cell proliferation, invasion, and the number of cells transitioning from the G0/G1 phase into the S phase of cell cycle and reduced the cellular apoptosis. Western blot analysis revealed that the expression of cell cycle progression-related proteins (CyclinD1, CyclinE, and CDK6) was significantly reduced, and the p21 expression was increased when interfering with both miR-486 and CADM1 expression. Conclusion Our results suggested that miR-486 could act as a tumor promoter by targeting CADM1 and be a potential therapeutic target for the treatment of OC.

Highlights

  • Ovarian cancer (OC) ranks the third among the most common malignancies of the female reproductive system, with the highest mortality rate among malignant gynecological tumors [1]

  • The results showed that cell proliferation, viability, and invasion were significantly reduced, apoptosis was significantly increased, and the proportion of cells in the G0/G1 phase was significantly increased, while in the S phase, it was significantly reduced in the in-miR-486 group (P < 0:05)

  • Previous studies have found that miR-486 is important in the development and prognosis of cancers [21]. miR-486 is expressed at low levels in a variety of malignant tumors, including oral tongue squamous cell carcinoma [22], cervical cancer [23], lung cancer [24], papillary thyroid carcinoma [25], and esophageal cancer [26]

Read more

Summary

Objective

To explore the role and possible underlying mechanism of miR-486 in ovarian cancer (OC) cells. The dual-luciferase reporter gene system was used to determine the targeting relationship between miR-486 and CADM1. Western blot was carried out to detect the expression of CADM1 protein and the proteins associated with cell cycle progression. Dual-luciferase reporter assays further confirmed that CADM1 was a target gene of miR-486. Interference with miR-486 could inhibit the proliferation and invasion and promoted the apoptosis of SKOV3 cells Knocking down both miR-486 and CADM1 significantly increased the SKOV3 cell proliferation, invasion, and the number of cells transitioning from the G0/G1 phase into the S phase of cell cycle and reduced the cellular apoptosis. Western blot analysis revealed that the expression of cell cycle progression-related proteins (CyclinD1, CyclinE, and CDK6) was significantly reduced, and the p21 expression was increased when interfering with both miR-486 and CADM1 expression. Our results suggested that miR-486 could act as a tumor promoter by targeting CADM1 and be a potential therapeutic target for the treatment of OC

Introduction
Materials and Methods
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call